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Background. A rotavirus vaccine previously licensed in the United States was withdrawn because it caused
intussusception. Data on background intussusception rates in developing countries are required to plan pre- and
postlicensure safety studies for new rotavirus vaccines. Also, it is unclear whether natural rotavirus infection is
associated with intussusception.
Methods. Passive surveillance for intussusception in a large, well-defined, poor, urban population in Delhi,
India, was conducted in 2 phases. Intussusception was confirmed by ultrasonography or surgery. Fecal samples
obtained from patients with intussusception at study hospitals (irrespective of their residence in study areas) and
healthy control subjects were tested for rotavirus with use of enzyme immunoassay. If available, resected intestinal
tissue samples were tested for rotavirus with use of immunohistochemistical analysis and reverse-transcription
polymerase chain reaction.
Results. The incidence of intussusception requiring hospitalization was 17.7 cases per 100,000 infant-years of
follow-up (95% confidence interval, 5.9–41.4 cases per 100,000 infant-years). Detection rates of rotavirus in stool
samples did not differ significantly between case patients and control subjects (4 of 42 case patients vs 6 of 92
control subjects), and no evidence of rotavirus was detected in any of the 22 patients with intussusception for
whom intestinal tissue samples were available.
Conclusions. The incidence of intussusception among Indian infants appears to be lower than that reported
in other middle- and high-income countries. Natural rotavirus infection does not appear to be a major cause of
intussusception in Indian infants.
Rotavirus is an important cause of diarrhea associated
with dehydration. It is estimated to be responsible for
∼150,000 deaths annually among Indian children !5
years of age [1]. The tetravalent rhesus-human reas-
sortant rotavirus vaccine was licensed in the United
States in August 1998. In mid-1999, the use of this
vaccine was reported to be associated with an increased
risk of intussusception, and the vaccine was withdrawn
from the market [2–4]. In 2006, phase 3 trials of 2 new
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rotavirus vaccines (Rotarix [GlaxoSmithKline], an at-
tenuated human rotavirus vaccine, and RotaTeq
[Merck], a pentavalent human-bovine reassortant ro-
tavirus vaccine) that involved 160,000 children each in
the Americas and Europe showed efficacy of 185%
against severe rotavirus disease and no increased risk
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of intussusception [5, 6]. These vaccines have been introduced
in national immunization programs in many countries, in-
cluding the United States, Mexico, and Brazil. Trials are ongoing
in several countries in Asia and Africa to demonstrate the ef-
ficacy of these rotavirus vaccines, and results are expected
within the next 2–3 years.
Data on background rates of intussusception in developing
countries are required to facilitate informed decision making
about use of new rotavirus vaccines. These background rates
are also needed for estimation of the sample size needed for
studies to demonstrate safety both before and after licensure
of new rotavirus vaccines. Such population-based data are not
available in most developing countries, including India. Also,
it is unclear whether natural rotavirus infection is associated
with intussusception. If natural rotavirus infection increases the
risk of intussusception, then some risk associated with rotavirus
vaccines might be considered to be acceptable.
To address these issues, we conducted passive surveillance to
estimate the incidence of intussusception in a well-defined,
poor, urban population in Delhi over a period of 3 years. Dur-
ing the same period, a case-control study was conducted to
examine the association of intussusception with natural rota-
virus infection.
METHODS
Population-Based Surveillance for Intussusception
Passive surveillance for hospitalized infants with intussuscep-
tion was conducted in 2 phases. The first phase lasted 2 calendar
years (December 2000–November 2002) and linked data from
active hospital-based surveillance of intussusception with cen-
sus data for children !5 years of age who lived in the sur-
rounding community. The community in South Delhi had a
population of ∼500,000 persons living in poor conditions.
Trained field workers conducted a baseline house-to-house sur-
vey to record the age and sex of all the children aged !5 years.
The age- and sex-specific population estimates were used as
the denominator for calculating the incidence of intussuscep-
tion. A total of 11,416 infants !1 year of age were identified.
Infant-years of follow up during the 2 years of surveillance
were calculated as twice this number, assuming that there was
no change in the number during the second year of surveillance.
Cases of intussusception were identified through surveillance
at 6 hospitals that account for approximately two-thirds of all
hospital admissions of children !5 years of age in the com-
munity. A study team led by a physician visited each of these
hospitals daily, screened all children admitted to the pediatric
medicine and pediatric surgery wards, and evaluated those with
prespecified clinical signs of intussusception. These clinical
signs included intermittent abdominal pain or excessive crying
of unknown origin, bloody (currant jelly) stools, abdominal or
rectal mass, recurrent vomiting not associated with acute di-
arrhea, and abdominal distension. A diagnosis of intussuscep-
tion was made on the basis of confirmation by either ultra-
sonography or surgery. The team then recorded identification
details of all patients to ascertain the number of patients who
belonged in the study population because they resided in the
defined study areas.
In the second phase, the participants were children enrolled
in an ongoing randomized controlled trial of zinc supplemen-
tation. These children (age, 1–23 months) were enrolled from
urban, poor areas in northern and northwestern Delhi and were
followed up for up to 1 year. Infant-years of follow-up were
calculated as the total number of months of follow-up that was
contributed by study participants during the first year of life.
Surveillance was conducted at 8 hospitals to identify study par-
ticipants who were hospitalized and to ascertain the cause of
hospital admissions. Children with the final hospital diagnosis
of intussusception were considered to have the condition.
Case-Control Study of the Association between Rotavirus
Infection and Intussusception
During the first phase of surveillance, infants admitted to any
of the hospitals, irrespective of their place of residence, who
had 1 sign of possible intestinal obstruction and who were
evaluated for possible intussusception were included in the
case-control study if they were aged 2–12 months and if parents
gave written informed consent. This study attempted to de-
termine whether natural rotavirus infection was associated with
intussusception.
Case patients. Infants, irrespective of their area of resi-
dence, were considered to be case patients if they were 2–12
months of age, had received a diagnosis of intussusception
confirmed by either ultrasonography or surgery, and were ad-
mitted to any of the 6 hospitals.
Control subjects. Infants were considered to be control
subjects if they were 2–12 months of age, were admitted to the
same hospitals as the case patients, and received a diagnosis
other than intussusception. Control subjects were enrolled con-
currently with the case patients but were not matched with
them by any criteria.
Assessment of case patients and control subjects. A ques-
tionnaire was completed for all case patients and control sub-
jects, and stool samples were collected. Intestinal tissue speci-
mens were also obtained whenever a case patient or control
subject required an intestinal resection. Two stool samples each
were collected from patients with intussusception and from
control subjects; one was collected on the day of hospital ad-
mission, and the other was collected 48 h after admission.
Samples were transferred to the laboratory at the All India
Institute of Medical Sciences (New Delhi, India) on ice and
were stored at 20C until analysis. Rotavirus was detected in
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Table 1. Characteristics of Patients with Intussusception and Control
Subjects
Characteristic
Case patients
(n p 47)
Control subjects
(n p 110)
Age, months, mean 6.0 4.6
Weight, kg 6.4 4.8
Male sex 37 (78.7) 79 (71.8)
Duration of illness, days, median (IQR) 3 (2–6) 6 (3–21)
Clinical presentation
Excessive crying and/or pain 29 (61.7) 43 (39.1)
Bloody and/or currant jelly stools 36 (76.6) 5 (4.6)
Abdominal and/or rectal mass 10 (21.3) 12 (10.9)
Recurrent vomiting 32 (68.1) 58 (52.7)
Abdominal distension 33 (70.2) 81 (73.6)
History of diarrhea in previous 2 weeks 10 (21.3) 22 (20.0)
Rotavirus detected in stool sample 4/42 6/92
NOTE. Data are no. (%) of participants, unless otherwise indicated. IQR, interquartile
range.
stool samples with use of commercially available enzyme im-
munoassay kits (Rotaclone; Meridian Diagnostics).
Evidence of rotavirus in resected intestinal tissue samples
from case patients and control subjects. For pathologic ex-
amination, all of the specimens were inspected grossly, and the
presence or absence of intussusception and other details were
noted. Multiple tissue sections were taken from different
regions of the surgically resected specimen of intestine and were
fixed in neutral-buffered formalin. Paraffin-embedded tissue
blocks were prepared for histological, immunohistochemical,
and reverse-transcription polymerase chain reaction (RT-PCR)
studies. Methods described by Tatti et al [7] were used for
immunohistochemical analysis and RT-PCR.
For histological studies, sections cut at 4 m were stained with
hemolysin and eosin. For immunohistochemical assays, rabbit
polyclonal IgG antibodies were used as primary antibodies. A
sepharose (Amersham) directed against the Wa strain was used
on 4-m–thick tissue sections. Before application, the primary
antibody sections were digested in 0.1 mg/dL of proteinase for
30 min. Specificity of staining was confirmed with preimmune
rabbit serum as primary antibody for negative control. Im-
munohistochemical staining was done with the streptavidine-
biotin alkaline phosphates technique, as described elsewhere
[7,8], with use of both positive and negative controls.
For RT-PCR, RNA was extracted from one 10-mm tissue
section placed in a microcentrifuge tube. Paraffin was removed
with xylene, and residual xylene was washed with alcohol. The
RNA was further extracted using a commercial kit (R Naid Plus
Kit; Bio 101). The 1-step RT-PCR kit and the conditions used
for RT-PCR to detect RNA of the VP4 gene have been described
in detail by Tatti et al [7]. The primer pair used to amplify a
product of 212 base pairs spanning nucleotides 676–887 of the
rotavirus VP4 gene (5′-TTG CCA CCA ATT CAG AAT AC-3′
[plus sense] and 5′–ATT TCG GAC CAT TTA TAA CC-3′ [mi-
nus sense]) was designed to be homologous to genotype P[4]
and P[8] reference strains.
RESULTS
Incidence of Intussusception during the First Year of Life
During the first phase of surveillance, 2 confirmed cases of
intussusception in infants aged !1 year who were from the
study population were identified after 22,832 infant-years of
follow-up. During the second phase, there were 3 confirmed
cases of intussusception among the enrolled infants aged !1
year after 20,496 infant-years of follow-up. Therefore, the total
incidence of intussusception requiring hospitalization was 17.7
cases per 100,000 infant-years of follow-up (95% confidence
interval, 5.9–41.4 cases per 100,000 infant-years), after inflation
of the crude incidence to adjust for ∼65% coverage of
surveillance.
Case-Control Study
Detection of rotavirus in stool samples from case patients and
control subjects. A total of 47 patients with intussusception
(2 of them in the study population and the remaining from
outside the study area) and 110 control subjects were enrolled,
irrespective of their area of residence (Table 1). Stool specimens
were available for testing from 42 case patients and 92 control
subjects, and detection rates of rotavirus did not differ signif-
icantly between case patients and control subjects (4 [10%] of
42 case patients vs 6 [7%] of 92 control subjects; age-adjusted
odds ratio, 1.60; 95% confidence interval, 0.42–6.16).
Examination of rotavirus in resected intestinal tissue spec-
imens from case patients and control subjects. Immuno-
histochemical staining failed to detect rotavirus antigen in sam-
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ples from any of the 22 patients with idiopathic intussusception
but yielded positive results for the positive control. None of
the patients with intussusception who had resected intestinal
tissue specimens examined for rotavirus had rotavirus detected
in stool samples. None of the 20 RNA extracts from formalin-
fixed, paraffin-embedded tissue samples from patients with in-
tussusception were positive for rotavirus RNA by RT-PCR; in
2 cases, PCR could not be performed.
DISCUSSION
Our study presents the first population-based estimates of in-
tussusception rates among infants in urban slums in Delhi,
India, and is one of the very few estimates from a developing
country. Intussusception rates among Indian infants were low
(∼18 cases per 100,000 infant years of follow-up). Studies from
middle- and high-income countries in Europe, Australia, Asia,
and the Americas have generally reported somewhat greater
intussusception rates of 30–70 cases per 100,000 infant-years
[9–18]; however, other studies from Asia have reported sub-
stantially greater rates of intussusception. A study among Viet-
namese infants reported a rate of 302 cases per 100,000 infant-
years [19], and a study from Japan reported a rate of 185 cases
per 100,000 infant-years [20]. It is possible that differences in
genetic predisposition or other factors possibly associated with
intussusception (eg, prevalence of enteric infection, feeding
practices, and prevalence of malnutrition) might explain the
differences in rates of intussusception among various popula-
tions. Of note, a recent study from Israel found that the in-
tussusception rates among Jewish children were more than
twice those among Bedouin children [21]. Differences in access
to medical care, methods of diagnosis (eg, ultrasound vs barium
enema), and treatment practices (eg, surgical management vs
outpatient enema reduction) might also explain some of the
variation in rates of hospitalization for intussusception among
various studies.
Infection with adenovirus has been well documented to be
associated with increased risk of intussusception [22–27], but
the literature on the association of intussusception with natural
rotavirus infection is less clear. Several studies from the 1970s
and 1980s reported high rates of rotavirus infection among
children treated for intussusception [28–30]. However, these
studies did not assess rotavirus infection among a healthy com-
parison group of infants; therefore, firm etiologic associations
could not be derived, especially because many of these studies
were conducted during the winter months, when rotavirus is
common in hospitalized children who could be susceptible to
nosocomial rotavirus infection. Around the time of the licen-
sure of the rhesus rotavirus vaccine in the late 1990s, many
ecological studies compared the seasonal patterns of intussus-
ception and hospitalizations for rotavirus infection, and found
that they differed substantially; this finding suggests that ro-
tavirus is not a major cause of intussusception [10, 14, 16, 31–
33]. An assessment of patients with intussusception and healthy
control subjects with use of ultrasound reported that rotavirus
infection was associated with increased distal ileum wall thick-
ness and lymphadenopathy during the illness period, suggesting
a plausible mechanism by which rotavirus infection could cause
intussusception [34]. However, several epidemiologic studies
using the case-control approach that have examined association
of intussusception with either all diarrheal diseases or labora-
tory-confirmed rotavirus disease have failed to show an asso-
ciation [19, 35, 36]. Our findings support these observations
and indicate that natural rotavirus infection is not associated
with intussusception in Indian children or that the risk of ro-
tavirus infection causing intussusception is extremely low.
Some potential limitations of the present study merit con-
sideration. It is possible that our surveillance did not capture
all patients in the source population, because they either did
not go to the hospitals under surveillance or because they died
at home without the parents seeking care in a hospital. We
adjusted the observed rates for the efficiency of our passive
surveillance (65% of all hospital admissions in the study area),
which was estimated through a household survey in the study
area. Even assuming that approximately one-half of the infants
with intussusception died at home without being hospitalized,
the actual incidence would still be !40 cases per 100,000 infant-
years of follow-up. A limitation of the case-control study was
the relatively small number of patients. However, we recruited
all patients with confirmed cases of intussusception who were
admitted to 6 of the largest hospitals in Delhi over a period of
2 calendar years. Poststudy calculations show that the current
sample size had ∼80% power to rule out an odds ratio of 4.
In conclusion, the incidence of intussusception among In-
dian children appears to be lower than that reported in other
middle- and high-income countries. The population-based
rates of intussusception reported in this study would be useful
for planning phase III and IV studies of rotavirus vaccines in
India. The lack of a strong association of intussusception with
natural rotavirus infection supports observations from other
studies and indicates that live oral rotavirus vaccines free of
this adverse effect can be developed. Although the exact path-
ogenesis of intussusception associated with the rhesus rotavirus
vaccine is not known [33, 37], new rotavirus vaccines do not
appear to be associated with intussusception on the basis of
data from large prelicensure trials [5, 6] and available post-
marketing data [38, 39]. However, because of the potential
differences in the risk of intussusception caused by different
rotavirus vaccines and variation in background rates of natural
intussusception in various populations, continued assessment
of this potential adverse event in association with rotavirus
vaccines is important. Our data will provide valuable baseline
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information to plan future trials of rotavirus vaccines in India
and to monitor vaccine safety after implementation.
DELHI INTUSSUSCEPTION STUDY HOSPITAL
GROUP
D. K. Gupta (All India Institute of Medical Sciences); Sumita
Mullick, Dal Chand, and Deepak Bagga (Safdarjang Hospital);
Ajay Jain and Rajiv Chadha (Kalawati Saran Children’s Hos-
pital); Arvind Sabharwal (Batra Hospital); Meera Luthra (Holy
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